Pyridoxal 5-phosphate monohydrate

Independent reference data for Pyridoxal 5-phosphate monohydrate (CAS 41468-25-1), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

• Investigated for use/treatment in coronary artery disease.
• MC-1 is a biologically active natural product which can be regarded as a chemical entity that has been evolutionarily selected and validated for binding to particular protein domains. Thus, its underlying structural architecture, or scaffold, has already been biologically established as safe and active, providing a powerful guiding principle for novel drug and library development.

Synonyms and trade names

Pyridoxal 5'-phosphate monohydrate; DTXSID7046594; DTXCID5026594; 4-Pyridinecarboxaldehyde, 3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-, monohydrate; 4-Pyridinecarboxaldehyde, 3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-, monohydrate; RefChem:870900; 4-Pyridinecarboxaldehyde, 3-hydroxy-2-methyl-5-(phosphonooxy)methyl-, monohydrate; 41468-25-1; Pyridoxal phosphate hydrate; (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate hydrate; Pyridoxal 5'-phosphate hydrate; Pyridoxal-5-phosphate Monohydrate; Tardoxal; PYRIDOXAL-5'-PHOSPHATE MONOHYDRATE; MFCD00149414; (4-Formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate hydrate(1:x)

Regulatory listings held on file

GHS hazard classification

What the public record says

Pyridoxal 5-phosphate monohydrate · CAS 41468-25-1 · C8H10NO6P.H2O. UNII 5V5IOJ8338.

Source: PubChem / Wikidata; the batch COA governs where values differ.